Biomerica (BMRA) Current Taxes (2012)

Biomerica (BMRA) reported Current Taxes of $19717.0 for Q3 2012, down 67.1% sequentially from $59938.0 in Q2 2012.

Biomerica (BMRA) Current Taxes (2012) Analysis & Trends

Biomerica (BMRA) has 1 years of Current Taxes data on file, last reported at $19717.0 in Q3 2012.

  • For the quarter ending Q3 2012, Current Taxes changed N/A year-over-year to $19717.0; the trailing twelve-month figure through Aug 2012 stood at $19717.0 (changed N/A YoY), and the FY2012 full-year result was $59938.0, changed N/A from the prior year.
  • Current Taxes fell to $19717.0 in Q3 2012, from $59938.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $59938.0 in Q2 2012 to a low of $19717.0 in Q3 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 598.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 476.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 914.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 231.81 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - 194.00 Mn
10 Biomerica 4.85 Mn 3.51 Mn -44,000.00 -

Historic Data

Download Data
DateValue
Aug 31, 2012 19,717.00
May 31, 2012 59,938.00
Feb 29, 2012 25,256.00